What is the prognostic impact of staged versus one-time multivessel percutaneous intervention in acute myocardial infarction?
The prognostic impact of staged versus one-time multivessel percutaneous intervention in acute myocardial infarction was analyzed from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. The results showed that one-time multivessel percutaneous intervention was associated with lower risk of in-hospital mortality, as well as a reduction in the risk of major adverse cardiovascular and cerebrovascular events at 1 year compared to staged multivessel percutaneous intervention. 